Cochrane · systematic review · CD010929
Yellow fever vaccine for patients with HIV infection
Barte, H, Horvath, TH, Rutherford, GW · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library
HIV/AIDSAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 3 · 75%Low 1 · 25%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Immunologic response to YF vaccine in HIV‐infected adults before HIV diagnosis, vs. immunologic response to YF vaccine in HIV‐infected adults after HIV diagnosis
Population: Adults with HIV infection
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Immunogenicity: Adequate antibody response (NT ≥1:10), Immunologic response to YF vaccine in HIV‐infected adults before HIV diagnosis, vs immunologic response to YF vaccine | RR 0.91 [0.85, 0.98] | 1 study · 364 participants | Low |
Immunologic response to YF vaccine in HIV‐infected children vs. immunologic response to YF vaccine in HIV‐uninfected children
Population: Children with HIV infection
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Adequate antibody response (NT ≥1:10), Immunologic response to YF vaccine in HIV‐infected children vs immunologic response to YF vaccine | RR 0.23 [0.08, 0.64] | 1 study · 75 participants | Very low |
Immunologic response to YF vaccine in HIV‐infected adults vs. immunologic response to YF vaccine in HIV‐uninfected adults
Population: Adults with HIV infection
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Immunogenicity: Adequate antibody response (NT ≥1:10), Immunologic response to YF vaccine in HIV‐infected adults vs immunologic response to YF vaccine | RR 0.86 [0.77, 0.96] | 1 study · 144 participants | Very low |
Duration: Adequate antibody response (NT ≥1:10), Immunologic response to YF vaccine in HIV‐infected adults vs immunologic response to YF vaccine | RR 0.88 [0.76, 1.02] | 1 study · 162 participants | Very low |